Expression of oncofetal fibronectin messenger ribonucleic acid in fibroblasts in the thyroid: A possible cause of false positive results in molecular-based diagnosis of thyroid carcinomas
T. Takano et al., Expression of oncofetal fibronectin messenger ribonucleic acid in fibroblasts in the thyroid: A possible cause of false positive results in molecular-based diagnosis of thyroid carcinomas, J CLIN END, 85(2), 2000, pp. 765-768
Oncofetal fibronectin (onfFN) messenger ribonucleic acid (mRNA) is abundant
ly expressed in thyroid papillary and anaplastic carcinomas. These carcinom
as can be preoperatively diagnosed by the detection of onfFN mRNA. in fine
needle aspiration biopsies (FNABs). However, previous reports have noted th
at the expression of onfFN mRNA was observed in 3.7% of the FNABs that were
diagnosed as negative cytology. To clarify this discrepancy, we examined t
he expression of onfFN mRNA in fibroblasts in the thyroid. By RT-PCR and re
al-time quantitative RT-PCR analyses, we detected a high copy number of onf
FN mRNA in cultured fibroblasts obtained from the normal thyroid tissues di
ssected surgically. Thus, we conclude that the contaminated fibroblasts in
FNABs due to tumor necrosis or acute or chronic inflammation may be a cause
of false positive results in molecular-based diagnosis of thyroid carcinom
as.